Baird Maintains Outperform on Inspire Medical Systems, Lowers Price Target to $200
Portfolio Pulse from Benzinga Newsdesk
Baird analyst Mike Polark maintains an Outperform rating on Inspire Medical Systems (NYSE:INSP) but lowers the price target from $220 to $200.
August 07, 2024 | 3:40 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Baird analyst Mike Polark maintains an Outperform rating on Inspire Medical Systems but lowers the price target from $220 to $200.
The Outperform rating suggests continued confidence in the company's performance, but the lowered price target indicates some caution. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100